First pre-clinical gene therapy study to reverse Rett symptoms
- Details
- Category: Research
The concept behind gene therapy is simple: deliver a healthy gene to compensate for one that is mutated. New research published today in the Journal of Neuroscience suggests this approach may eventually be a feasible option to treat Rett Syndrome, the most disabling of the autism spectrum disorders.
Coffee and tea may contribute to a healthy liver
- Details
- Category: Research
Your morning cup of tea or coffee may be doing more than just perking you up before work. An international team of researchers led by Duke-NUS Graduate Medical School (Duke-NUS) and the Duke University School of Medicine suggest that increased caffeine intake may reduce fatty liver in people with non-alcoholic fatty liver disease (NAFLD).
Celery, artichokes contain flavonoids that kill human pancreatic cancer cells
- Details
- Category: Research
Celery, artichokes, and herbs, especially Mexican oregano, all contain apigenin and luteolin, flavonoids that kill human pancreatic cancer cells in the lab by inhibiting an important enzyme, according to two new University of Illinois studies.
Targeting aggressive prostate cancer
- Details
- Category: Research
A team of researchers from UC Davis, UC San Diego and other institutions has identified a key mechanism behind aggressive prostate cancer. Published on August 14, 2013 in Nature, the study shows that two long non-coding RNAs (PRNCR1 and PCGEM1) activate androgen receptors, circumventing androgen-deprivation therapy. In their active state, these receptors turn on genes that spur growth and metastasis, making these cancers highly treatment-resistant.
Virus-derived particles target blood cancer
- Details
- Category: Research
Ottawa researchers have developed unique virus-derived particles that can kill human blood cancer cells in the laboratory and eradicate the disease in mice with few side effects. The study is published in Blood Cancer Journal by co-senior authors Drs. David Conrad and John Bell of the Ottawa Hospital Research Institute (OHRI) and the University of Ottawa (uOttawa).
Preclinical tests may lead to new approach to treat CNS lymphoma
- Details
- Category: Research
A drug recently approved for use in multiple myeloma is now being tested for its ability to fight central nervous system (CNS) lymphoma, a deadly cancer of the immune system that can affect the brain, spinal cord and fluid, and eyes. The clinical trial, now open at the three campuses of Mayo Clinic - in Florida, Minnesota and Arizona - follows successful testing of the drug, pomalidomide, in mouse models of CNS lymphoma.
Chocolate may help keep brain healthy
- Details
- Category: Research
Drinking two cups of hot chocolate a day may help older people keep their brains healthy and their thinking skills sharp, according to a study published in the August 7, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study involved 60 people with an average age of 73 who did not have dementia.
More Pharma News ...
- Injectable 'smart sponge' holds promise for controlled drug delivery
- New drugs to find the right target to fight Alzheimer's disease
- Scientists discover potential new way to treat anxiety
- Placebo effects of different therapies not identical
- New modular vaccine design combines best of existing vaccine technologies
- Molecular robots can help researchers build more targeted therapeutics
- Researchers target HER1 receptor for peptide cancer vaccine, therapeutic agents